New Strategic Partnership: Impilo + Ash Bring Diagnostics and Devices Together for Smarter At-Home Care
Managing chronic care from home just got easier. In case you missed it, Impilo recently announced a strategic partnership with Ash, a leading at-home health testing platform. Together, we are combining Remote Patient Monitoring (RPM) devices and diagnostic kits into a single, integrated platform to streamline how patients and providers manage care from home.
Why RPM and Diagnostic Testing Matter for Modern Care
Remote Patient Monitoring (RPM) devices collect and transmit vital health data such as heart rate, blood pressure, weight, and oxygen saturation from patients to their healthcare providers. These devices often include wearable sensors that sync data in real-time, enabling clinicians to observe health trends and intervene early when issues arise.
Diagnostic kits are compact, user-friendly tools designed to analyze patient samples (such as blood, saliva, or urine) for biomarkers of disease. These kits empower patients and clinicians with quick, reliable test results, often without the need for a clinic visit.
All-in-One Kits for Effortless Home Care
This partnership unifies diagnostic testing and remote patient monitoring (RPM) into one streamlined solution, delivering a seamless experience that includes:
Point-in-time testing for immediate clinical insights
Continuous health tracking through connected devices
Real-time alerts that enable timely, proactive interventions
By merging diagnostics with RPM, we’re empowering smarter decision-making and more personalized care at scale.
Extending Access and Closing the Care Loop
This partnership streamlines the at-home care experience by deploying custom, cohesive kits to your patients. These kits can include diagnostic testing and RPM devices to deliver continuous monitoring and testing right to your patient's door. More importantly, this partnership is designed to close care gaps and improve outcomes.
By sending both testing kits and RPM devices directly to patients’ doors, Impilo’s platform eliminates common barriers such as travel, appointment backlogs, and limited clinic access. The result: earlier detection, timely interventions, and improved chronic care management, while supporting key quality metrics. The result is not only improved patient outcomes but also more equitable healthcare delivery that reaches those who have traditionally been left behind.
Conclusion
By integrating diagnostic kits with remote patient monitoring (RPM) devices, healthcare is becoming smarter, more seamless, and increasingly decentralized. As the boundaries between home and clinic dissolve, this convergence isn’t just a breakthrough; it’s the future. Impilo and Ash are at the forefront, driving scalable, equitable care that meets people wherever they are.
Want to simplify how you deliver diagnostic tests and remote patient monitoring (RPM) devices directly to your patients? Contact us at sales@impilo.health to discover how Impilo + Ash can help streamline your process.
